Yarrow Bioscience (YARW) Change in Inventory (2019 - 2022)
Yarrow Bioscience's (YARW) quarterly Change in Inventory came in at -$97000.0 in Q1 2022, down 114.1% YoY from $688000.0 in Q1 2021, and up 87.55% on a QoQ basis from -$779000.0 in Q4 2021.
Yarrow Bioscience (YARW) Change in Inventory (2019 - 2022) Analysis & Trends
Yarrow Bioscience (YARW) has 4 years of Change in Inventory data on file, last reported at -$97000.0 in Q1 2022.
- Quarterly Change in Inventory fell 114.1% year-over-year to -$97000.0 in Q1 2022, while the trailing twelve-month figure through Dec 2022 was -$97000.0 (up 14.16% YoY) and the FY2022 annual result came in at -$97000.0, up 14.16% from the prior year.
- Change in Inventory grew to -$97000.0 in Q1 2022, from -$779000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $2.6 million in Q2 2020 to a low of -$779000.0 in Q4 2021.
- A 4-year average of $719400.0 and a median of $721000.0 in 2020 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2020 — Change in Inventory tumbled 44.4% — and 2021, when it tumbled 203.32%.
- Tracing YARW's Change in Inventory over 4 years: stood at $1.4 million in 2019, then plunged by 44.4% to $754000.0 in 2020, then plunged by 203.32% to -$779000.0 in 2021, then jumped by 87.55% to -$97000.0 in 2022.
- The last three Change in Inventory figures came in at -$97000.0 (Q1 2022), -$779000.0 (Q4 2021), and -$209000.0 (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Yarrow Bioscience | 31.25 Mn | 8.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -97,000.00 |
| Mar 31, 2022 | -97,000.00 |
| Dec 31, 2021 | -779,000.00 |
| Dec 31, 2021 | -779,000.00 |
| Sep 30, 2021 | -209,000.00 |
| Sep 30, 2021 | -209,000.00 |
| Jun 30, 2021 | 187,000.00 |
| Jun 30, 2021 | 187,000.00 |
| Mar 31, 2021 | 688,000.00 |
| Mar 31, 2021 | 688,000.00 |
| Dec 31, 2020 | 754,000.00 |
| Dec 31, 2020 | 754,000.00 |
| Sep 30, 2020 | 849,000.00 |
| Sep 30, 2020 | 849,000.00 |
| Jun 30, 2020 | 2.60 Mn |
| Jun 30, 2020 | 2.60 Mn |
| Mar 31, 2020 | 1.85 Mn |
| Mar 31, 2020 | 1.85 Mn |
| Dec 31, 2019 | 1.36 Mn |
| Dec 31, 2019 | 1.36 Mn |